| |
|
|
|
Oasmia Pharmaceutical AB (publ)  
|
|
2.2416 0.062 (0.03%) |
04-18 15:33 |
|
Open: |
2.1571 |
Pre close: |
2.18 |
Target:
|
3.18
|
|
High: |
2.358 |
Low: |
2.2416 |
Resistance:
|
2.72
3.06
|
|
Volume: |
4,398 |
Market Cap: |
174M |
Support:
|
2.18
1.81
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
2.28
 |
MACD |
MACD(12,26):
|
-0.09 |
|
MA(20): |
2.28  |
Signal(12,26,9): |
-0.10 |
|
MA(100): |
2.86 |
Stochastic Oscillator |
%K(14,3):
|
35.86 |
|
MA(250): |
2.60 |
%D(3): |
42.95 |
|
Average Volume(K) |
3-Month: |
652
|
52-Week |
High:
|
5.70 |
|
10-Days: |
634 |
Low: |
1.20 |
|
RSI |
RSI(14):
|
43.40 |
Change(%): |
24.6 |
|
Financials, Statistics and Valuation |
|
EPS |
0.000 |
Return on Equity (ttm) |
-40.5 |
Shares Out. (M) |
74.97 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-27.4 |
Shares Float (M) |
74.97 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
29.6 |
% Held by Institutions |
0.20 |
|
Forward EPS |
0.000 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
0 |
|
Book Value (p.s.) |
3.950 |
EBITDA (p.s.) |
0.000 |
P/E |
0.00 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.57 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
0.00 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
0.00 |
P/CF |
0.00 |
|
|
|
|
|
|
